Topics Covered
We invite you to learn more about:
- Emerging therapies for acute myeloid leukemia (AML)
- Precision medicine for AML
- Managing side-effects
- The importance of open communication with your treatment team
Program Materials
/sites/default/files/2021-06/slides_aml_6.22.21.pdf
/sites/default/files/2022-06/transcript_aml_6.22.21.pdf
Speaker
Joseph G. Jurcic, MD
Professor of Medicine
Columbia University Irving Medical Center
Director, Hematologic Malignancies
Attending Physician, New York-Presbyterian Hospital
Member, Herbert Irving Comprehensive Cancer Center
New York, NY
Program Support
Support for this program is provided by Agios; Bristol Myers Squibb; Genentech, Inc. & Biogen, and Jazz Pharmaceuticals.